Ownership history in B Group, Inc. · 4 quarters on record
This page tracks every 13F SEC filing in which B Group, Inc. reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 232,446 | — | 0% | 8.12% | $11.0M | — |
| 2025 Q2 | REDUCED | 232,446 | -10,054 | -4.1% | 9.55% | $12.4M | — |
| 2025 Q1 | REDUCED | 242,500 | -17,500 | -6.7% | 8.41% | $9.8M | — |
| 2024 Q4 | INITIATED | 260,000 | — | — | 4.42% | $7.2M | — |